Skip to main content

Advertisement

SpringerLink
Log in

Treatment of Osteoporosis in Men

  • Osteoporosis in Men
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. E Orwoll M Ettinger S Weiss P Miller D Kendler J Graham S Adami K Weber R Lorenc P Pietschmann K Vandormael A Lombardi (2000) ArticleTitleAlendronate for the treatment of osteoporosis in men N Engl J Med 343 604–610 Occurrence Handle10.1056/NEJM200008313430902 Occurrence Handle1:CAS:528:DC%2BD3cXmsFSqs7k%3D Occurrence Handle10979796

    Article  CAS  PubMed  Google Scholar 

  2. ID Ringe H Faber A Dorst (2001) ArticleTitleAlendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study J Clin Endocrinol Metab 86 5252–5255 Occurrence Handle10.1210/jc.86.11.5252 Occurrence Handle1:CAS:528:DC%2BD3MXos1Kqs7c%3D Occurrence Handle11701687

    Article  CAS  PubMed  Google Scholar 

  3. TJ Weber MK Drezner (2001) ArticleTitleEffect of alendronate on bone mineral density in male idiopathic osteoporosis Metabolism 50 912–915 Occurrence Handle10.1053/meta.2001.24925 Occurrence Handle1:CAS:528:DC%2BD3MXlvVClu7Y%3D Occurrence Handle11474478

    Article  CAS  PubMed  Google Scholar 

  4. S Gonnelli C Cepollaro A Montagnani D Bruni C Caffarelli M Breschi L Gennari C Gennari R Nuti (2003) ArticleTitleAlendronate treatment in men with primary osteoporosis: a three-year longitudinal study Calcif Tissue Int 73 133–139 Occurrence Handle10.1007/s00223-002-1085-7 Occurrence Handle1:CAS:528:DC%2BD3sXntVWlurg%3D Occurrence Handle14565594

    Article  CAS  PubMed  Google Scholar 

  5. YV Ho AG Frauman W Thomson E Seeman (2000) ArticleTitleEffects of alendronate on bone density in men with primary and secondary osteoporosis Osteoporos Int 11 98–101 Occurrence Handle1:CAS:528:DC%2BD3cXjs1Wmt78%3D Occurrence Handle10793867

    CAS  PubMed  Google Scholar 

  6. Miller P, Orwoll E, MacIntyre B, Smith M, Vandormeal K, Leung A (2003) Treatment with alendronate 70 mg once weekly for 12 months increases BMD and decreases biochemical markers of bone turnover in men with osteoporosis. Second International Conference on Osteoporosis in Men, Genoa, Italy

  7. S Greenspan E Field–Munves R Tonino M Smith R Petruschke L Wang J Yates A Papp Particlede J Palmisano (2002) ArticleTitleTolerability of once-weekly alendronate in patients with osteoporosis: a randomized, double-blind, placebo-controlled study Mayo Clin Proc 77 1044–1052 Occurrence Handle1:CAS:528:DC%2BD38Xot1Wqur0%3D Occurrence Handle12374248

    CAS  PubMed  Google Scholar 

  8. JD Ringe E Orwoll A Daifotis A Lombardi (2002) ArticleTitleTreatment of male osteoporosis: recent advances with alendronate Osteoporos Int 13 195–199 Occurrence Handle10.1007/s001980200013 Occurrence Handle1:CAS:528:DC%2BD38XksVyntrc%3D Occurrence Handle11991437

    Article  CAS  PubMed  Google Scholar 

  9. JD Ringe A Dorst H Faber (2003) ArticleTitleRisedronate reduces vertebral fractures in men with osteoporosis J Bone Miner Res 18 S160

    Google Scholar 

  10. DM Reid RA Hughes RFJM Laan NA Sacco–Gibson DH Wenderoth S Adami RA Eusebio JP Devogelaer (2000) ArticleTitleEfficacy and safety of daily residronate in the treatment of corticosteroid-induced osteoporosis in men and women A J Bone Miner Res 15 1006–1013 Occurrence Handle1:CAS:528:DC%2BD3cXktFKhtbs%3D

    CAS  Google Scholar 

  11. S Wallach S Cohen DM Reid RA Hughes DJ Hosking RF Laan SM Doherty M Maricic C Rosen J Brown I Barton AA Chines (2000) ArticleTitleEffects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy Calcif Tissue Int 67 277–285 Occurrence Handle10.1007/s002230001146 Occurrence Handle1:CAS:528:DC%2BD3cXntlOlu74%3D Occurrence Handle11000340

    Article  CAS  PubMed  Google Scholar 

  12. KG Saag R Emkey TJ Schnitzer JP Brown F Hawkins S Goemaere G Thamsborg UA Liberman PD Delmas M-P Malice M Czachur AG Diafotis (1998) ArticleTitleAlendronate for the prevention and treatment of glucocorticoid-induced osteoporosis N Engl J Med 339 292–299 Occurrence Handle10.1056/NEJM199807303390502 Occurrence Handle1:CAS:528:DyaK1cXlsVOitr4%3D Occurrence Handle9682041

    Article  CAS  PubMed  Google Scholar 

  13. JD Adachi KG Saag PD Delmas UA Liberman RD Emkey E Seeman NE Lane JM Kaufman PEE Poubelle F Hawkens R Correa–Rotter C Menkes JA Rodriguez–Portales TJ Schnitzer JA Block J Wing HH McIlwain R Westhovens J Brown JA Melo-Gomes BL Gruber MJ Yanover M Leite KG Siminoski MC Nevitt JT Sharp M Malice T Dumortier M Czachur W Carofano A Daifotis (2001) ArticleTitleTwo-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids Arthritis Rheum 44 202–211 Occurrence Handle10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W Occurrence Handle1:CAS:528:DC%2BD3MXht1yiu7o%3D Occurrence Handle11212161

    Article  CAS  PubMed  Google Scholar 

  14. MR Smith FJ McGovern AL Zietman MA Fallen DL Hayden DA Schoenfeld PW Kantoff JS Finkelstein (2001) ArticleTitlePamidronate to prevent bone loss during androgen-deprivation therapy for prostate cancer N Engl J Med 345 948–955 Occurrence Handle10.1056/NEJMoa010845 Occurrence Handle1:CAS:528:DC%2BD3MXntlehtbs%3D Occurrence Handle11575286

    Article  CAS  PubMed  Google Scholar 

  15. ES Kurland F Cosman DJ McMahon C Rosen R Lindsay JP Bilezikian (2000) ArticleTitleParathyroid hormone as a therapy for idiopathic osteoporosis in men: effects on bone mineral density and bone markers J Clin Endocrinol Metab 85 3069–3076 Occurrence Handle10.1210/jc.85.9.3069 Occurrence Handle1:CAS:528:DC%2BD3cXmsVKrurk%3D Occurrence Handle10999788

    Article  CAS  PubMed  Google Scholar 

  16. ES Orwoll WH Scheele S Paul S Adami U Syversen A Diez–Perez JM Kaufman AD Clancy GA Gaich (2003) ArticleTitleThe effect of teriparatide [Human Parathyroid Hormone (1–34)] therapy on bone density in men with osteoporosis J Bone Miner Res 18 9–17 Occurrence Handle1:CAS:528:DC%2BD3sXltFKmtw%3D%3D Occurrence Handle12510800

    CAS  PubMed  Google Scholar 

  17. ES Orwoll WH Scheele AD Clancy S Adami U Syversen JM Kaufman (2001) ArticleTitleRecombinant human parathyroid hormone (1–34) increases bone mineral density in men with both idopathic and hypogonadal osteoporosis Arthritis Rheum 44 S379

    Google Scholar 

  18. NE Lane S Sanchez GW Modin HK Genant E Pierini CD Arnaud (1998) ArticleTitleParathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial J Clin Invest 102 1627–1633 Occurrence Handle1:CAS:528:DyaK1cXmvVynsL0%3D Occurrence Handle9788977

    CAS  PubMed  Google Scholar 

  19. HM Behre S Kliesch E Leifke TM Link E Nieschlag (1997) ArticleTitleLong-term effect of testosterone therapy on bone mineral density in hypogonadal men J Clin Endocrinol Metab 82 2386–2390 Occurrence Handle10.1210/jc.82.8.2386 Occurrence Handle1:CAS:528:DyaK2sXltFGmu7w%3D Occurrence Handle9253305

    Article  CAS  PubMed  Google Scholar 

  20. C Wang G Alexander N Berman B Salehian T Davidson V McDonald B Steiner L Hull C Callegari RS Swerdloff (1996) ArticleTitleTestosterone replacement therapy improves mood in hypogonadal men—A clinical research center study J Clin Endocrinol Metab 81 3578–3583 Occurrence Handle10.1210/jc.81.10.3578 Occurrence Handle1:CAS:528:DyaK28XmtlCmt7c%3D Occurrence Handle8855804

    Article  CAS  PubMed  Google Scholar 

  21. PJ Snyder H Peachey P Hannoush JA Berline L Loh JH Holmes A Dlewati J Staley J Santanna SC Kapoor MF Attie JG Haddad BL Strom (1999) ArticleTitleEffect of testosterone treatment on bone mineral density in men over 65 years of age J Clin Endocrinol Metab 84 1966–1972 Occurrence Handle10.1210/jc.84.6.1966 Occurrence Handle1:CAS:528:DyaK1MXjs1Ohsr4%3D Occurrence Handle10372695

    Article  CAS  PubMed  Google Scholar 

  22. JP Bilezikian A Morishima J Bell MM Grumbach (1998) ArticleTitleIncreased bone mass as a result of estrogen therapy in a man with aromatase deficiency N Engl J Med 339 599–603 Occurrence Handle10.1056/NEJM199808273390905 Occurrence Handle1:STN:280:DyaK1cznt1Cmsw%3D%3D Occurrence Handle9718379

    Article  CAS  PubMed  Google Scholar 

  23. S Khosla J Melton SuffixIII BL Riggs (2002) ArticleTitleEstrogen and the male skeleton J Clin Endocrinol Metab 87 1443–1450 Occurrence Handle10.1210/jc.87.4.1443 Occurrence Handle1:CAS:528:DC%2BD38XivFKlsbw%3D Occurrence Handle11932262

    Article  CAS  PubMed  Google Scholar 

  24. JD Ringe A Dorst C Kipshoven LC Rovati I Setniker (1998) ArticleTitleAvoidance of vertebral fractures in men with idiopathic osteoporosis by a three year therapy with calcium and low-dose intermittent monofluorophosphate Osteoporos Int 8 47–52 Occurrence Handle10.1007/s001980050047 Occurrence Handle1:CAS:528:DyaK1cXitlWrt7s%3D Occurrence Handle9692077

    Article  CAS  PubMed  Google Scholar 

  25. JS Finkelstein A Hayes JL Hunzelman JJ Wyland H Lee RM Neer (2003) ArticleTitleThe effects of parathyroid hormone, alendronate, or obth in men with osteoporosis. N Eng J Med 349 1216–1226 Occurrence Handle10.1056/NEJMoa035725 Occurrence Handle1:CAS:528:DC%2BD3sXns1Kmsrs%3D

    Article  CAS  Google Scholar 

  26. JK Armory NB Watts KA Easley PR Sutton BD Anawalt A Matsumoto WJ Bremner JL Tenover (2004) ArticleTitleExogenous testosterone or testosterone with finasteride increase in bone mineral density in older men with low serum testosterone. J Clin Endocrinol Metab 89 501–502 Occurrence Handle10.1210/jc.2003-032160 Occurrence Handle14764752

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bone and Mineral Unit, Oregon Health and Sciences University and the Veterans Administration Medical Center, Portland, OR, 97201, USA

    E. S. Orwoll

  2. Oregon Health and Sciences University, HRC 11D36 (CR113), 3181 SW Sam Jackson Park, Portland, OR, 87201, USA

    E. S. Orwoll

Authors
  1. E. S. Orwoll
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. S. Orwoll.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Orwoll, E.S. Treatment of Osteoporosis in Men. Calcif Tissue Int 75, 114–119 (2004). https://doi.org/10.1007/s00223-004-0288-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00223-004-0288-5

Keywords

Search

Navigation